We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$609M
AUM Growth
+$24.7M
Cap. Flow
+$613K
Cap. Flow %
0.1%
Top 10 Hldgs %
29.26%
Holding
182
New
17
Increased
47
Reduced
54
Closed
11

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$11.9M
2
SBUX icon
Starbucks
SBUX
+$7.81M
3
MAT icon
Mattel
MAT
+$4.88M
4
AXP icon
American Express
AXP
+$4.18M
5
AAPL icon
Apple
AAPL
+$2.63M

Sector Composition

Rank Sector Weight
1 Financials 17.51%
2 Technology 15.14%
3 Healthcare 15.01%
4 Consumer Discretionary 10.68%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
126
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$253K 0.04%
16,060
ECL icon
127
Ecolab
ECL
$78.6B
$250K 0.04%
1,940
-110
-5% -$14.5K
ADXS
128
DELISTED
Advaxis Inc
ADXS
$250K 0.04%
3,987
+134
+3% +$12.4K
PNC icon
129
PNC Financial Services
PNC
$100B
$249K 0.04%
1,848
ZTS icon
130
Zoetis
ZTS
$32.3B
$245K 0.04%
3,846
HPQ icon
131
HP
HPQ
$24.8B
$241K 0.04%
12,050
WMB icon
132
Williams Companies
WMB
$86.1B
$240K 0.04%
8,000
TGT icon
133
Target
TGT
$67.8B
$236K 0.04%
4,000
-722
-15% -$40.4K
MAT icon
134
Mattel
MAT
$4.32B
$232K 0.04%
15,000
-273,126
-95% -$4.88M
UNH icon
135
UnitedHealth
UNH
$377B
$230K 0.04%
1,175
SPGI icon
136
S&P Global
SPGI
$123B
$229K 0.04%
1,466
ARLZ
137
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$227K 0.04%
99,229
ACN icon
138
Accenture
ACN
$101B
$219K 0.04%
+1,624
New +$212K
RYN icon
139
Rayonier
RYN
$6.48B
$217K 0.04%
8,267
RDS.A
140
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$212K 0.03%
+3,500
New +$196K
VEU icon
141
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$211K 0.03%
4,000
NOC icon
142
Northrop Grumman
NOC
$77.9B
$210K 0.03%
+730
New +$196K
CEMP
143
DELISTED
Cempra, Inc.
CEMP
$210K 0.03%
64,550
+19,300
+43% +$68.2K
ACAD icon
144
Acadia Pharmaceuticals
ACAD
$4.39B
$203K 0.03%
+5,400
New +$176K
BTI icon
145
British American Tobacco
BTI
$128B
$203K 0.03%
+3,257
New +$210K
PSTB
146
DELISTED
Park Sterling Corp.
PSTB
$191K 0.03%
15,384
HPE icon
147
Hewlett Packard
HPE
$66.5B
$177K 0.03%
12,050
-3,482
-22% -$47.5K
AEO icon
148
American Eagle Outfitters
AEO
$2.99B
$143K 0.02%
+10,000
New +$122K
BLCM
149
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$142K 0.02%
+1,229
New +$129K
NVLN
150
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$141K 0.02%
20,000

Similar funds

Franklin Street Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Franklin Street Advisors held 182 positions worth $609M, up 4.2% from $585M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Franklin Street Advisors's Q3 2017 filing shows 17 new, 47 increased, 54 reduced and 11 closed positions. Its largest new stake was Marriott International: 60,035 shares worth $6.62M. The largest sale was Praxair Inc, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Franklin Street Advisors's largest Q3 2017 buy was Marriott International: 60,035 shares worth $6.62M.
  • Franklin Street Advisors added most to DuPont de Nemours in Q3 2017, an estimated $8.2M increase.
  • Franklin Street Advisors's biggest Q3 2017 reduction was Mattel, cutting an estimated $4.88M.
  • Franklin Street Advisors fully exited Praxair Inc in Q3 2017, selling an estimated $11.9M.
  • Franklin Street Advisors's ten largest holdings make up 29% of its $609M portfolio in Q3 2017.
  • Franklin Street Advisors opened 17 new positions and closed 11 in Q3 2017.
  • Franklin Street Advisors's portfolio value rose 4.2% quarter-over-quarter to $609M.

Based on Franklin Street Advisors's 13F filing for Q3 2017, filed 11 Oct 2017.